Instruments, Tech
Platforms, Informatics and Market
Published: March 2003
155 pages;
Can be printed; fully searchable PDF format; TOC hyperlinks and Internet hyperlinks
SKU:
TPR3139
Price:
$1,695.00 (US Dollars) PDF Single
User License
$1,995.00 (US Dollars) PDF Single
Office License (2 to 5 users)
$2,295.00 (US Dollars) PDF Global
Site License
Description
This market research report is
about the important market for life science tools & techs that are used for accelerating the research processes and capabilities of biopharmaceutical R&D. This
key research information is valuable and offers readers a detailed overview of the size and shape of the life science tools and techs market and what the
products can do to facilitate the advancement of pharmaceutical and biotech drug R&D programs.
Significant life science industry
information is presented and reviewed. While pharmaceutical industry generated more than $255 billion in 2002, pharma companies are facing many important issues
that could be helped by using new life science tools and technologies. A broad range of industry data is analyzed and reveals that pharma companies have seen
their R&D costs dramatically increase over the last twenty years, while their product productivity has declined. In addition, many existing and profitable
blockbuster drugs will reach patent expiration dates between 2005-2006. This situation will attract competition from generic or other branded drug makers. It
shows that there is a clear need driving the desire for more innovation.
For buyers and sellers of life
science tools and techs, this report shows that major pharma companies have increasingly become a source of significant strategic alliance opportunities for
many of the companies that comprise the US biotechnology industry. Major pharma companies are motivated to become customers and partners of life science tools
companies because the many "tools" companies offer technologies that enable them become more productive, reduce bottlenecks and deliver more marketable
products, at less cost, and in a shorter time than in the current 10 to 15-year sequential drug development timeline.
Industrialization of
pharmaceutical and biotech R&D has begun. These firms are using genomics and proteomics technologies, and other life science tools that can help these
companies reach their drug product objectives. The report discusses some of the newest life science tools and tech advancements including nanobiotechnology,
rolling circle amplification technology (RCAT), ICAT, RNAi, phage display, yeast 2 hybrid, PROfusion technology, surface plasmon resonance, biochips, protein
arrays, separation technologies, 2D PAGE, HPLC, TOF/TOF, drug target discovery and validation tools among others.
This report has found that the
life science tools & techs market size in 2002 was about $1.6 billion and is projected to more than double to about $3.5 billion by 2007, growing at a CAGR of
17.7%. While the economy is currently challenging this market, a pickup in growth is expected after 2004. Readers will learn about key business opportunities
and the lessons learned from the life science tools and techs companies. This 155-page study uses 34 figures and tables to illustrate the research findings.
Participating companies are mapped against multiple technologies to show where they fit in the competitive landscape. Over 27 life science tools & tech
companies are profiled, and the report provides insights about the "tools & techs" that these interesting companies offer, including their strategies, funding
and so on.
Table of Contents
1.Overview of the Life Science
Tools & Technology Market
The Competitive Marketplace
Analytical Instrumentation
Companies
Genomics Companies
Proteomics Companies
Bioinformatics Software
Companies
BioDatabase Companies
Drug Discovery Companies
Emerging Tools & Technology
Companies
Reagent and Consumables
Companies
Overview of Life Science Tool
& Tech Developments
Gene Sequencing Systems
Protein Separation Tools
Mass Spectrometers (MS)
Microarray and Microfluidic
Analytical Technologies
Emerging Technologies
Informatics - IT for Life
Science R&D
Life Science Tool & Tech
Applications for R&D
Biopharmaceutical Drug
Discovery
R&D Diagnostic Tools
Pharming Applications
2.Factors Driving Life Science
Tools & Tech Developments
The Opportunity to Make
Multi-Billion Dollar Revenues
The Pace of Pharmaceutical
Mergers and Acquisitions
Rapid Pace of Scientific
Advancements
Economics of Pharmaceutical
R&D
Drug Discovery R&D
Creation of Post-Genomic Era
R&D Databases
Proteomics R&D Requires New
Tools & Techs
3.Strategies for Life Science
Tools & Techs for R&D
Business Models and
Intellectual Property
Business Models
Intellectual Property (IP)
Commercializing Life Science
Tools & Techs.
Develop and Out-License
Technology
Produce and Sell Consumable
Products for R&D
Produce and Sell Equipment
Platforms to R&D Customers
Discover or Validate Drug
Targets for Drug Discovery
Strategic Goals
Establish Customer Base with
Large Pharmas or Biotechs
Make Key Alliances or
Partnerships
Grow the Company to Reach
Critical Mass
Business Development
Strategies
Traditional Alliance
Partnering
Become a Technology Roll-up
Merge with Another Biotech
4.Market Forecast
Life Science Tools & Tech R&D
Market Size by Segment, 2002~2007
5.Activities of Analytical
Instrument Companies
Affymetrix, Inc.
Agilent Technologies, Inc.
(Life Sciences)
Cepheid
Ciphergen Biosystems, Inc.
6.Activities of Bioinformatics
Companies
Accelrys, Inc (Subsidiary of
Pharmacopeia Inc.)
Celera Genomics Corporation
Gene Logic, Inc.
Human Genome Sciences, Inc.
Incyte Corporation
InforMax, Inc. (Acq. by
Invitrogen)
Spotfire, Inc.
7.Activities of Drug Discovery
Tools Companies
AVIVA Biosciences
Caliper Technologies
Corporation
Fluidigm Corporation
GeneMachines, Inc.
Nanogen, Inc.
8.Activities of Emerging
Technology Companies
BioTrove
Illumina, Inc.
Nanostream
PamGene
Xeotron Corporation
Zyomyx, Inc.
9.Activities of Reagent &
Consumables Companies
ACLARA BioSciences, Inc.
Genicon Sciences Corporation
Invitrogen Corporation
Molecular Staging, Inc.
Phylos, Inc.
Quantum Dot Corporation
10.Future Directions of Life
Science Tools for R&D
Future Directions
Review of Recent Trends
Recent Developments in
Genomics That Impact Life Science Tools
Indicators of Future Trends
Financing Volatility
Biotechnology Conferences
University Labs at Work
Bioinformatics Software.
Bioinformatics Databases
Emerging Protein Technology
Nanobiotechnology
Opportunities Emerging
11.Conclusions and New
Opportunities
Factors for Success or Failure
Highlights of Hot Development
Areas of Life Science Tools
Life Science Tools & Tech
Opportunities
Industrial Scale Proteomics
The Trend Towards
Individualized Medicine
Summary
12.Appendix A. Tech Map of
Industry Segments
Target Identification
Genomic Technologies
Target Identification
Protein Technologies
Protein Chip
Protein Databases
Target Validation
Drug Lead Screening
Preclinical Development
Phase I-III Clinical
Development & Diagnostics
13.Appendix B. Technology Map
Tables - Life Science Tools & Tech
Companies
14.Appendix C. Life Science
Glossary
List of Tables
Table 1. Estimated Total Life
Science Tools & Techs. Market Size
by Segment
Revenues
Table 2. Total Life Science Tools
& Tech Market Segments by
Market Share
Percent
Table 3. Drug Discovery Tools
Segment by Revenues
Table 4. Bioinformatics Tools
Segment by Revenues
Table 5. Reagents and Consumables
Segment by Revenues
Table 6. Emerging Technologies
Segment by Revenues
Table 7. Future Directions of
Life Science Tools & Techs for R&D
Table 8. Major Drug Discovery
Tools Companies
Table 9. Major Bioinformatics
Tools Companies
Table 10. Major Life Science
Reagent & Consumables Vendors
Table 11. Major Emerging
Technologies Companies
Table 12. Major Drug Discovery
Companies
List of Figures
Figure 1. Life Science Tools &
Techs Vendor Market
Figure 2. The R&D Path to Make
Drug Products
Figure 3. Liquid Handling
Systems
Figure 4. Incyte's Protein
Expression Analysis Software
Figure 5. ScreenMate Products for
HTS in Drug Lead R&D
Figure 6. Rolling Circle
Amplification Technology (RCAT)
Figure 7. RNA Interference: Steps
to Making siRNA
Figure 8. The InforMax ProChart™
for Protein Visualization
Figure 9. Computer Model using
PhysioLab Technology
Figure 10. Big Pharma and Big
Biotech Drug R&D Timeline
Figure 11. Using Parallel
Processes to Increase Drug Discovery Productivity
Figure 12. Estimated Total Life
Science Tools & Techs Market Size by Revenues
Figure 13. Estimated Total Life
Science Tools & Tech Market Size
by Segment Revenues,
2002-2007
Figure 14. Comparison of
Estimated Total Life Science Tools & Tech Market
Size by Segment
Revenues, 2002-2007
Figure 15. Comparison of Segment
Market Shares for the Life Science
Tools & Tech Market,
2002 and 2007
Figure 16. Drug Discovery Tools
Segment by Revenues
Figure 17. Bioinformatics Tools
Segment by Revenues
Figure 18. Reagents and
Consumable Life Science Tools Segment by Revenues
Figure 19. Emerging Technologies
Segment by Revenues
Figure 20. Spotfire DecisionSite
Figure 21. Accelrys GCG Wisconsin
Package – SeqLab
Figure 22. The Incyte/ Oxford
Glycoscience Proteome Analysis Process
Figure 23. Life Science Tools &
Techs Opportunity Map
For more information or to order the above publications,
call 1-510-796-9129 or fax 1-510-796-9129.
Copyright © 1996-2012 TAKEDA PACIFIC. All Rights Reserved.